vs
ATLANTIC AMERICAN CORP（AAME）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ATLANTIC AMERICAN CORP的1.4倍（$75.5M vs $53.8M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 20.8%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $6.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.2%）
大西洋电报公司成立于1856年11月6日，主要业务是铺设并运营跨大西洋商业电报电缆，这也是人类历史上第一条跨大西洋的电信通信链路。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
AAME vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$53.8M
营收增速更快
PBYI
高出7.0%
20.8%
自由现金流更多
PBYI
多$7.8M
$6.6M
两年增速更快
PBYI
近两年复合增速
7.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.8M | $75.5M |
| 净利润 | $577.0K | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 1.4% | 22.7% |
| 净利率 | 1.1% | — |
| 营收同比 | 20.8% | 27.7% |
| 净利润同比 | 128.9% | — |
| 每股收益（稀释后） | $0.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AAMEPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | $53.8M | $54.5M | ||
| Q2 25 | $55.3M | $52.4M | ||
| Q1 25 | $50.1M | $46.0M | ||
| Q4 24 | $49.0M | $59.1M | ||
| Q3 24 | $44.5M | $80.5M | ||
| Q2 24 | $47.7M | $47.1M | ||
| Q1 24 | $47.0M | $43.8M |
净利润AAMEPBYI
| Q4 25 | — | — | ||
| Q3 25 | $577.0K | $8.8M | ||
| Q2 25 | $3.3M | $5.9M | ||
| Q1 25 | $802.0K | $3.0M | ||
| Q4 24 | $412.0K | — | ||
| Q3 24 | $-2.0M | $20.3M | ||
| Q2 24 | $-684.0K | $-4.5M | ||
| Q1 24 | $-2.0M | $-4.8M |
毛利率AAMEPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率AAMEPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | 1.4% | 17.6% | ||
| Q2 25 | 7.6% | 12.7% | ||
| Q1 25 | 2.1% | 8.7% | ||
| Q4 24 | 1.1% | 22.6% | ||
| Q3 24 | -5.5% | 27.4% | ||
| Q2 24 | -1.8% | -4.6% | ||
| Q1 24 | -5.3% | -5.3% |
净利率AAMEPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | 16.2% | ||
| Q2 25 | 6.0% | 11.2% | ||
| Q1 25 | 1.6% | 6.5% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | -4.5% | 25.2% | ||
| Q2 24 | -1.4% | -9.6% | ||
| Q1 24 | -4.3% | -11.0% |
每股收益（稀释后）AAMEPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $0.15 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $-0.10 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $-0.10 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $109.5M | $130.3M |
| 总资产 | $430.9M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AAMEPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | $34.4M | $94.4M | ||
| Q2 25 | $46.4M | $96.0M | ||
| Q1 25 | $35.9M | $93.2M | ||
| Q4 24 | $35.6M | $101.0M | ||
| Q3 24 | $23.0M | $96.7M | ||
| Q2 24 | $21.2M | $96.8M | ||
| Q1 24 | $21.2M | $107.2M |
总债务AAMEPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益AAMEPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | $109.5M | $115.3M | ||
| Q2 25 | $106.2M | $104.7M | ||
| Q1 25 | $102.4M | $97.1M | ||
| Q4 24 | $99.6M | $92.1M | ||
| Q3 24 | $105.8M | $71.1M | ||
| Q2 24 | $100.7M | $48.5M | ||
| Q1 24 | $102.8M | $51.0M |
总资产AAMEPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | $430.9M | $202.9M | ||
| Q2 25 | $429.3M | $194.9M | ||
| Q1 25 | $388.4M | $196.2M | ||
| Q4 24 | $393.4M | $213.3M | ||
| Q3 24 | $387.0M | $220.7M | ||
| Q2 24 | $386.0M | $205.0M | ||
| Q1 24 | $365.8M | $214.1M |
负债/权益比AAMEPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $6.6M | $14.4M |
| 自由现金流率自由现金流/营收 | 12.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 11.51× | — |
| 过去12个月自由现金流最近4个季度 | $19.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流AAMEPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $6.6M | $9.7M | ||
| Q2 25 | $9.3M | $14.1M | ||
| Q1 25 | $-722.0K | $3.6M | ||
| Q4 24 | $4.8M | $15.6M | ||
| Q3 24 | $90.0K | $11.0M | ||
| Q2 24 | $416.0K | $1.0M | ||
| Q1 24 | $-5.3M | $11.2M |
自由现金流AAMEPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $6.6M | $9.7M | ||
| Q2 25 | $9.1M | $14.1M | ||
| Q1 25 | $-986.0K | $3.6M | ||
| Q4 24 | $4.6M | $15.6M | ||
| Q3 24 | $58.0K | $11.0M | ||
| Q2 24 | $361.0K | $1.0M | ||
| Q1 24 | $-5.4M | — |
自由现金流率AAMEPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | 12.3% | 17.7% | ||
| Q2 25 | 16.5% | 26.8% | ||
| Q1 25 | -2.0% | 7.7% | ||
| Q4 24 | 9.3% | 26.4% | ||
| Q3 24 | 0.1% | 13.7% | ||
| Q2 24 | 0.8% | 2.1% | ||
| Q1 24 | -11.4% | — |
资本支出强度AAMEPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率AAMEPBYI
| Q4 25 | — | — | ||
| Q3 25 | 11.51× | 1.10× | ||
| Q2 25 | 2.80× | 2.41× | ||
| Q1 25 | -0.90× | 1.21× | ||
| Q4 24 | 11.65× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
PBYI
暂无分部数据
